Cetera Advisors LLC Charles River Laboratories International, Inc. Transaction History

Cetera Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$203.52 - $273.43 $453,239 - $608,928	2,227 Added 197.08%	3,357 $909,000
Q4 2023 Feb 13, 2024	BUY	$164.52 - $238.84 $185,907 - $269,889	1,130 New	1,130 $267,000
Q2 2023 Aug 09, 2023	BUY	$183.71 - $210.25 $177,463 - $203,101	966 New	966 $203,000
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $207,951 - $263,823	1,055 New	1,055 $229,000
Q2 2022 Aug 11, 2022	SELL	$204.13 - $302.4 $153,097 - $226,799	-750 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$255.51 - $362.11 $58,767 - $83,285	-230 Reduced 23.47%	750 $213,000
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $180,960 - $231,070	-515 Reduced 34.45%	980 $369,000
Q3 2021 Nov 16, 2021	BUY	$372.64 - $458.3 $281,343 - $346,016	755 Added 102.03%	1,495 $617,000
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $2,059 - $2,601	7 Added 0.95%	740 $274,000
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $183,008 - $219,518	733 New	733 $212,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.